Home

Scientists + Trainees

Learn more about OICR's programs, funding opportunities and careers.

OICR RESEARCHER

If we can do a better job of determining that there is no residual disease after surgery, then we could potentially spare patients adjuvant radiation therapy.

CAREERS@OICR

To learn more about OICR's job opportunities, please visit our Careers page.

Industry

Learn more about OICR's commercialization program, IPDC Fund and investment opportunities.

OICR FUNDED PROJECT

Cellax™ is a drug-polymer conjugate nanoparticle that accumulates in tumours, resulting in increased therapeutic benefits and reduced side effects.